Lecheng special access (pre-NMPA drugs & devices)

乐城特许药械通道

Available in China through a designated special-access channel.
485+
catalogue items
36
institutions
14
overseas patients (2025)
Full details

What it treats

Oncology & rare disease products approved by FDA/EMA/PMDA but not yet NMPA

How China compares internationally

International comparison
Access play: only place in mainland China to use these products legally

How international patients can pursue this

Overseas patients generally access these centres through a hospital's international department or special-needs (特需) service rather than the ordinary public clinic. Eligibility depends on diagnosis, disease status, prior treatment and clinical assessment. This page is general information, not medical advice.

Next steps

Browse hospitalsView official regulatory sourcesCompare hospitals← All treatments

Sources & verification

Overall status: Primary-source verified.

Reader discussion

Public comments about Lecheng special access (pre-NMPA drugs & devices). Discussion is not medical advice, and a comment is not an endorsement or a verified fact. Open the full forum.